What is the recommended amikacin dose and administration schedule for a 5‑month‑old infant weighing 4.2 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amikacin Dosing for a 5-Month-Old Infant Weighing 4.2 kg

For this 5-month-old infant weighing 4.2 kg, administer amikacin 15-30 mg/kg/day as a single daily dose (63-126 mg/day), given either intramuscularly or intravenously over 30-60 minutes. This dosing range is supported by FDA labeling and multiple clinical guidelines for pediatric patients.

Recommended Dosing Strategy

Standard Dosing

  • Dose range: 15-30 mg/kg/day 1, 2, 1, 3
  • For this 4.2 kg infant: 63-126 mg once daily
  • Route: Intramuscular or intravenous
  • Frequency: Once daily (every 24 hours)

The FDA label explicitly states for children: "15-30 mg/kg per day (1 g/day maximum) intramuscular or intravenous as a single daily dose" 3. This wide dosing range allows for adjustment based on infection severity and pathogen susceptibility.

Special Considerations for Young Infants

For infants under 1 week of age, a different regimen applies: loading dose of 10 mg/kg followed by 7.5 mg/kg every 12 hours 3. However, at 5 months of age, this infant should receive the standard pediatric dosing described above.

Administration Details

Intravenous Administration

  • Infusion time: 1-2 hours for infants (longer than the 30-60 minutes used for adults) 3
  • Preparation: Dilute in sufficient fluid volume to allow the extended infusion time
  • Do not premix with other drugs; administer separately 3

Intramuscular Administration

  • Single daily injection at the calculated dose
  • Rotate injection sites

Therapeutic Drug Monitoring (TDM)

TDM is essential in pediatric patients to ensure efficacy while minimizing toxicity 3:

Target Concentrations

  • Peak: 25-35 mcg/mL (for daily dosing) 4
  • Trough: <5 mcg/mL (ideally <3 mg/L for safety) 4, 3
  • Peak concentrations above 35 mcg/mL and trough concentrations above 10 mcg/mL should be avoided 3

Timing of Levels

  • Peak: Draw 60-120 minutes after infusion ends 4
  • Trough: Draw immediately before next dose
  • Initial monitoring: Obtain peak level in first week, then weekly trough levels for 4 weeks 4

Dosing Adjustments

For Renal Impairment

If renal function is compromised (unlikely at this age but important to assess):

  • Reduce dosing frequency rather than dose amount to maintain concentration-dependent killing 1, 2, 1
  • Monitor serum creatinine twice weekly initially 4

Maximum Daily Dose

  • Total daily dose should not exceed 15 mg/kg/day by all routes of administration for prolonged therapy 3
  • For severe infections, the higher end of the 15-30 mg/kg range may be used initially

Safety Monitoring

Baseline Assessment

  • Renal function (serum creatinine)
  • Hearing assessment if feasible (audiogram baseline)
  • Vestibular function assessment 1, 2

Ongoing Monitoring

  • Renal function: Twice weekly during month 1, weekly during month 2, then fortnightly 4
  • Auditory symptoms: Question caregivers about hearing changes at each visit
  • Duration: Limit treatment to 7-10 days when feasible 3

Key Toxicity Concerns

Ototoxicity

Amikacin causes primarily auditory toxicity (hearing loss) rather than vestibular dysfunction 1, 2. High-frequency hearing loss occurred in 24% of patients in one study, with higher rates at longer durations and higher cumulative doses 1, 2. This risk necessitates careful monitoring and limiting treatment duration.

Nephrotoxicity

Amikacin may be more nephrotoxic than streptomycin 1, 2. Renal impairment occurred in 8.7% of patients overall, but only 3.4% in those without risk factors 1, 2. In this young infant, ensure adequate hydration and avoid concurrent nephrotoxic agents.

Clinical Pearls

  • Once-daily dosing is preferred over divided doses due to concentration-dependent bactericidal activity and potentially reduced toxicity
  • The 15-30 mg/kg range allows flexibility: use lower doses (15-20 mg/kg) for less severe infections or organisms with lower MICs, and higher doses (25-30 mg/kg) for severe infections or resistant organisms
  • Treatment duration of 7-10 days is typical; if treatment beyond 10 days is needed, reassess necessity and intensify monitoring 3
  • For this 4.2 kg infant, practical dosing would be approximately 80-100 mg once daily (19-24 mg/kg), which falls within the recommended range and allows for standard vial preparation

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.